Review
Published on 13 Jun 2025
Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626492
- 750 views
Type at least 3 characters
1,761 articles
Original Research
Published on 11 Jun 2025
Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1579699
- 458 views
Mini Review
Published on 10 Jun 2025
Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1615526
- 848 views
Systematic Review
Published on 10 Jun 2025
Effects of dupilumab on quality of life in patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1587977
- 1,149 views
Original Research
Accepted on 09 Jun 2025
Exploring the Beneficial Effects of GHK-Cu on an Experimental Model of Colitis and the Underlying Mechanisms
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551843
- 133 views
Systematic Review
Published on 09 Jun 2025
Comparative effectiveness and safety of tofacitinib vs. adalimumab in patients with rheumatoid arthritis: A systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1524214
- 1,118 views
Review
Published on 09 Jun 2025
Targeting the cGAS-STING pathway: emerging strategies and challenges for the treatment of inflammatory skin diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597443
- 801 views
Original Research
Published on 05 Jun 2025
Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572604
- 1,149 views
Original Research
Published on 30 May 2025
Biodegradable sustained-release microneedle patch loaded with clindamycin hydrochloride: a breakthrough in acne management
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575635
- 945 views
Review
Published on 30 May 2025
Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577628
- 1,081 views
Original Research
Published on 30 May 2025
Determination of nine prostaglandins in the arachidonic acid metabolic pathway with UHPLC-QQQ-MS/MS and application to in vitro and in vivo inflammation models
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595059
- 684 views
Review
Published on 23 May 2025
Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598022
- 1,184 views
Review
Published on 19 May 2025
The key players of inflammasomes and pyroptosis in sepsis-induced pathogenesis and organ dysfunction
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586364
- 1,252 views
Review
Published on 19 May 2025
Immunopharmacology of gastric cancer–deciphering immune cell subset responses and nanoparticle-mediated targeting
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1611234
- 999 views
Editorial
Published on 16 May 2025
Editorial: Inflammation and lipid signaling in disease pathogenesis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1623707
- 744 views
Original Research
Published on 14 May 2025
The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559812
- 1,214 views